Stocksigma LogoStocksigma Logo

Cohance Lifesciences Approves ESOP Grants and Allots 25,600 Equity Shares

On 6th Nov'26, Cohance Lifesciences approved the grant of 69,028 stock options under ESOP 2026 (exercise price minimum INR 325 or max 20% discount to

Cohance Lifesciences Approves ESOP Grants and Allots 25,600 Equity Shares

Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 6:44 pm

Cohance Lifesciences Approves ESOP Grants and Allots 25,600 Equity Shares On 6th Nov'26, Cohance Lifesciences approved the grant of 69,028 stock options under ESOP 2026 (exercise price minimum INR 325 or max 20% discount to 21-day average market price) and 1,03,542 stock options under ESOP 2023 at an exercise price of INR 495. Additionally, the company allotted 25,600 equity shares of INR 1 face value at an exercise price of INR 268 per share pursuant to ESOP 2023 exercises, expanding total issued share capital to 38,26,22,930 equity shares aggregating INR 38,26,22,930.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements